Loading this company
IQVIA Holdings Inc.
IQVPrices in USD
TickerWorth ScoreD43/100
What we think
Priced above our range of $106.87 to $255.57.
Price
$276.63USD up +$8.78 (+3.28%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
$106.87–$255.57
What the price needs: revenue growth of 22.9%/yr for 5 years (our model assumes 5.8%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price $276.63Priced · Prices are delayed.
Is it a good business?
- Valuation17 out of 100
- Growth50 out of 100
- Financial health0 out of 100
- Past performance100 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro.
Try Pro free for 7 days — no card, auto-downgrade to Free.
The street
Analysts’ mean target
$300.95 across 19 analysts
Lowest to highest target $268.00 – $345.00
What does it do?
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates in the Diagnostics & Research industry (Healthcare sector), headquartered in United States. The company employs roughly 94,000 people.
Key stats
52-week range$154.50–$277.40
- Open
- $264.46
- Day high
- $277.28
- Day low
- $263.97
- Previous close
- $267.85
- Volume
- 1,751,917 · 1.19× avg
- Average volume
- 1,468,607
- Market cap
- $45,533,298,688.00
- P/E (TTM)
- 33.29
- Earnings per share
- $8.31
- Beta
- 1.17
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Signed a material agreement
- Disclosed another material event
- Reported quarterly or annual results
- Signed a material agreement
- Disclosed another material event
- Disclosed another material event
- Disclosed another material event
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro.
Try Pro free for 7 days — no card, auto-downgrade to Free.
Not investment advice. TickerWorth Score is a model output.